We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+261.51%
AUM
$464M
AUM Growth
+$9.84M
Cap. Flow
-$1.22M
Cap. Flow %
-0.26%
Top 10 Hldgs %
23.12%
Holding
1,212
New
213
Increased
248
Reduced
228
Closed
162

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$10.3M
2
EMC
EMC CORPORATION
EMC
+$5.07M
3
CTSH icon
Cognizant
CTSH
+$4.73M
4
CDW icon
CDW
CDW
+$4.52M
5
LYB icon
LyondellBasell Industries
LYB
+$4.32M

Sector Composition

Rank Sector Weight
1 Healthcare 13.06%
2 Technology 12.02%
3 Financials 11.96%
4 Industrials 10.82%
5 Consumer Staples 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVIX
826
DELISTED
VelocityShares Daily 2x VIX Short Term ETN
TVIX
0
FNSR
827
DELISTED
Finisar Corp
FNSR
$3K ﹤0.01%
+95
New +$2.08K
AAL icon
828
American Airlines Group
AAL
$10.6B
$2K ﹤0.01%
60
-125
-68% -$4.42K
ACCO icon
829
Acco Brands
ACCO
$407M
$2K ﹤0.01%
+210
New +$2.16K
AEE icon
830
Ameren
AEE
$30B
$2K ﹤0.01%
42
+7
+20% +$357
AMH icon
831
American Homes 4 Rent
AMH
$12.4B
$2K ﹤0.01%
76
-34
-31% -$736
AU icon
832
AngloGold Ashanti
AU
$44.3B
$2K ﹤0.01%
+122
New +$2.32K
BBY icon
833
Best Buy
BBY
$16.9B
$2K ﹤0.01%
46
-7
-13% -$246
BGC icon
834
BGC Group
BGC
$4.97B
$2K ﹤0.01%
311
BBT
835
Beacon Financial Corp
BBT
$2.67B
$2K ﹤0.01%
+75
New +$2.05K
BIS icon
836
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.18M
$2K ﹤0.01%
9
BNY
837
Bank of New York Mellon
BNY
$108B
$2K ﹤0.01%
+59
New +$2.36K
BX icon
838
Blackstone
BX
$107B
$2K ﹤0.01%
60
-300
-83% -$7.92K
CATY icon
839
Cathay General Bancorp
CATY
$4.26B
$2K ﹤0.01%
75
CCEP icon
840
Coca-Cola Europacific Partners
CCEP
$47.9B
$2K ﹤0.01%
53
-226
-81% -$8.62K
CNOB icon
841
Center Bancorp
CNOB
$1.8B
$2K ﹤0.01%
115
CRI icon
842
Carter's
CRI
$1.48B
$2K ﹤0.01%
+25
New +$2.51K
CUK
843
DELISTED
Carnival PLC
CUK
$2K ﹤0.01%
+47
New +$2.21K
CYBR
844
DELISTED
CyberArk
CYBR
$2K ﹤0.01%
40
CYTK icon
845
Cytokinetics
CYTK
$11B
$2K ﹤0.01%
+190
New +$1.98K
DEI icon
846
Douglas Emmett
DEI
$1.93B
$2K ﹤0.01%
60
-7
-10% -$259
DRRX
847
DELISTED
DURECT Corp
DRRX
$2K ﹤0.01%
+165
New +$2.71K
DVA icon
848
DaVita
DVA
$11.5B
$2K ﹤0.01%
36
+7
+24% +$493
ENSG icon
849
The Ensign Group
ENSG
$10.6B
$2K ﹤0.01%
107
EPAM icon
850
EPAM Systems
EPAM
$4.86B
$2K ﹤0.01%
35

Similar funds

Howe & Rusling's Q3 2016 Portfolio in Review

As of Q3 2016, Howe & Rusling held 1,212 positions worth $464M, up 2.2% from $454M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Howe & Rusling's Q3 2016 filing shows 213 new, 248 increased, 228 reduced and 162 closed positions. Its largest new stake was Citizens Financial Group: 206,875 shares worth $5.11M. The largest sale was CVS Health, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Howe & Rusling's largest Q3 2016 buy was Citizens Financial Group: 206,875 shares worth $5.11M.
  • Howe & Rusling added most to Medtronic in Q3 2016, an estimated $6.09M increase.
  • Howe & Rusling's biggest Q3 2016 reduction was CVS Health, cutting an estimated $10.3M.
  • Howe & Rusling fully exited EMC CORPORATION in Q3 2016, selling an estimated $5.07M.
  • Howe & Rusling's ten largest holdings make up 23% of its $464M portfolio in Q3 2016.
  • Howe & Rusling opened 213 new positions and closed 162 in Q3 2016.
  • Howe & Rusling's portfolio value rose 2.2% quarter-over-quarter to $464M.

Based on Howe & Rusling's 13F filing for Q3 2016, filed 17 Oct 2016.